Q4 2025 Earnings Call February 25, 2026 8:30 AM ESTCompany ParticipantsMaria Lycouris - Investor RelationsOran Holtzman - ...
Myriad Genetics (MYGN) jumps on an earnings beat, raising 2026 revenue targets to $860M-$880M and highlighting oncology test growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results